ResMed (RMD) Misses Q3 EPS by 10c
Tweet
Share
E-mail
Get Alerts RMD Hot Sheet
Price: $221.97 --0%
EPS Growth %: +5.5%
Financial Fact:
Income from operations: 94.15M
Today's EPS Names:
NEOV, MANU, CTAS, More
EPS Growth %: +5.5%
Financial Fact:
Income from operations: 94.15M
Today's EPS Names:
NEOV, MANU, CTAS, More
Join SI Premium – FREE
ResMed (NYSE: RMD) reported Q3 EPS of $1.32, $0.10 worse than the analyst estimate of $1.42. Revenue for the quarter came in at $864.5 million versus the consensus estimate of $897.04 million.
For earnings history and earnings-related data on ResMed (RMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Royal Caribbean to acquire 50% stake in Sandals Resorts for $3 billion
- JPMorgan Downgrades Shenzhen Inovance Tech (300124:CH) to Neutral
- MillerKnoll, Inc. (MLKN) Tops Q1 EPS by 18c ; Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
